Literature DB >> 20536511

Mortality of young patients with diabetes in Kinshasa, DR Congo.

M T Muyer1, F Buntinx, M A Mapatano, M De Clerck, C Truyers, E Muls.   

Abstract

AIMS: As data on mortality of young patients with diabetes is not available in the Democratic Republic of Congo (DRC), we studied mortality rates, the influence of some determinants and causes of death.
METHODS: A retrospective review of standardized medical records of all patients with diabetes aged<or=30 years at diagnosis who were enrolled between 1994 and 2004 in a large, integrated healthcare network in Kinshasa, DRC. Diabetes was diagnosed clinically. As resources for classification according to type of diabetes were not available, the study sample was a mixed-type cohort. Death was established by review of medical records and by community interview. Mortality was recorded until 2007. Overall mortality rates and 95% confidence intervals (CI) were calculated. Kaplan-Meier survival and Cox regression analyses were performed to study the influence of determinants.
RESULTS: Of the patients, 17.4% (159/915) died, mostly during the first 5 years of follow-up. Mean yearly mortality was 3.62/100 patient-years (95% CI 3.1-4.2). Independent predictors were male gender [hazard ratio (HR) 0.66 (95% CI 0.5-0.9) for females vs. males] and age at diagnosis (HR 0.97 (95% CI 0.94-0.99) per increase of 1 year]. Major causes of death were ketoacidosis (38%) and infection (12%). Cause of death was unknown in 31% of cases.
CONCLUSIONS: One out of six patients died, most within 5 years after diagnosis. Death occurred more frequently at home, in male patients and in subjects aged<or=20 years. The major cause of death was ketoacidosis.

Entities:  

Mesh:

Year:  2010        PMID: 20536511     DOI: 10.1111/j.1464-5491.2010.02961.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  5 in total

Review 1.  The impact of health systems on diabetes care in low and lower middle income countries.

Authors:  David Beran
Journal:  Curr Diab Rep       Date:  2015-04       Impact factor: 4.810

2.  Substrate metabolism, hormone and cytokine levels and adipose tissue signalling in individuals with type 1 diabetes after insulin withdrawal and subsequent insulin therapy to model the initiating steps of ketoacidosis.

Authors:  Thomas S Voss; Mikkel H Vendelbo; Ulla Kampmann; Steen B Pedersen; Thomas S Nielsen; Mogens Johannsen; Mads V Svart; Niels Jessen; Niels Møller
Journal:  Diabetologia       Date:  2018-12-01       Impact factor: 10.122

3.  The insulin dilemma in resource-limited countries. A way forward?

Authors:  G V Gill; J S Yudkin; H Keen; D Beran
Journal:  Diabetologia       Date:  2010-09-12       Impact factor: 10.122

4.  Type 1 diabetes in 2017: global estimates of incident and prevalent cases in children and adults.

Authors:  Anders Green; Simone M Hede; Christopher C Patterson; Sarah H Wild; Giuseppina Imperatore; Gojka Roglic; David Beran
Journal:  Diabetologia       Date:  2021-10-02       Impact factor: 10.122

5.  Management of type 1 diabetes in low- and middle-income countries: Comparative health system assessments in Kyrgyzstan, Mali, Peru and Tanzania.

Authors:  Aida Abdraimova; Stéphane Besançon; Jill Portocarrero; Kaushik Ramaiya; Asel Dunganova; Margaret Ewen; Hans Hogerzeil; Maria Lazo-Porras; Richard Laing; Molly Lepeska; Happy Nchimbi; Assa Sidibé; Andrew Swai; Janeth Tenorio-Mucha; John S Yudkin; Jessica H Zafra-Tanaka; Aida Zurdinova; David Beran
Journal:  Diabet Med       Date:  2022-06-06       Impact factor: 4.213

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.